• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从人红细胞中大规模分离1型补体受体(CR1)。蛋白水解片段化研究。

Large-scale isolation of complement receptor type 1 (CR1) from human erythrocytes. Proteolytic fragmentation studies.

作者信息

Sim R B

出版信息

Biochem J. 1985 Dec 15;232(3):883-9. doi: 10.1042/bj2320883.

DOI:10.1042/bj2320883
PMID:2936334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1152965/
Abstract

A large-scale procedure for the isolation of complement receptor type 1 (CR1, the C3b receptor) from human erythrocytes is described. Two of the four known phenotypes of CR1 are detectable in the isolated material. Amino acid and hexosamine analysis of the A phenotype (Mr 240 000) indicates a polypeptide chain length of about 2030 amino acids and a carbohydrate content of 8%. Both N- and O-linked sugars appear to be present. Trypsin digestion of isolated CR1 shows that it is degraded rapidly and extensively, and no stable products of Mr greater than 25000 are found. The ability of the receptor to bind to solid-phase ligand is destroyed after a single cleavage by trypsin. The capacity of the receptor to act as a cofactor for Factor I-mediated cleavage of soluble C3b is, however, only gradually decreased by proteolysis, and 30% of this activity remains after extensive degradation. The same pattern of loss of binding to solid-phase ligand, with partial retention of interaction with soluble ligand, is also characteristic of the complement proteins Factor H and C4bp, which are functionally related to CR1.

摘要

本文描述了一种从人红细胞中分离补体受体1型(CR1,即C3b受体)的大规模方法。在分离出的物质中可检测到CR1四种已知表型中的两种。对A表型(分子量240 000)进行氨基酸和己糖胺分析表明,其多肽链长度约为2030个氨基酸,碳水化合物含量为8%。N-连接糖和O-连接糖似乎都存在。对分离出的CR1进行胰蛋白酶消化显示,它迅速且大量地被降解,未发现分子量大于25000的稳定产物。受体与固相配体结合的能力在被胰蛋白酶单次切割后即被破坏。然而,受体作为I因子介导的可溶性C3b裂解辅因子的能力仅因蛋白水解而逐渐降低,在广泛降解后仍保留30%的这种活性。与固相配体结合能力丧失,而与可溶性配体相互作用部分保留的相同模式,也是与CR1功能相关的补体蛋白H因子和C4bp的特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4cf/1152965/015fda1a6204/biochemj00289-0255-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4cf/1152965/420565ee033b/biochemj00289-0254-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4cf/1152965/015fda1a6204/biochemj00289-0255-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4cf/1152965/420565ee033b/biochemj00289-0254-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4cf/1152965/015fda1a6204/biochemj00289-0255-a.jpg

相似文献

1
Large-scale isolation of complement receptor type 1 (CR1) from human erythrocytes. Proteolytic fragmentation studies.从人红细胞中大规模分离1型补体受体(CR1)。蛋白水解片段化研究。
Biochem J. 1985 Dec 15;232(3):883-9. doi: 10.1042/bj2320883.
2
Solubilization of active complement receptor type 1 (CR1) from human erythrocyte stroma with trypsin and its purification.用胰蛋白酶从人红细胞基质中溶解活性补体受体1(CR1)并进行纯化。
J Biochem. 1986 Nov;100(5):1193-200. doi: 10.1093/oxfordjournals.jbchem.a121823.
3
Analysis of C3b/C4b receptor (CR1) polymorphic variants by tryptic peptide mapping.通过胰蛋白酶肽图谱分析C3b/C4b受体(CR1)多态性变体。
Mol Immunol. 1986 Jun;23(6):661-8. doi: 10.1016/0161-5890(86)90104-5.
4
Loss of complement receptor type 1 (CR1) on ageing of erythrocytes. Studies of proteolytic release of the receptor.红细胞衰老过程中补体受体1(CR1)的丧失。受体蛋白水解释放的研究。
Biochem J. 1986 May 1;235(3):815-21. doi: 10.1042/bj2350815.
5
Characterization of the human erythrocyte complement receptor CR1 (C3b receptor) by epitope mapping.通过表位作图对人红细胞补体受体CR1(C3b受体)进行表征。
Immunobiology. 1987 Jan;174(1):93-106. doi: 10.1016/S0171-2985(87)80087-6.
6
Structural and functional studies on the human C3b/C4b receptor (CR1) purified by affinity chromatography using a monoclonal antibody.使用单克隆抗体通过亲和色谱法纯化的人C3b/C4b受体(CR1)的结构与功能研究
Complement. 1986;3(2):63-78. doi: 10.1159/000467882.
7
Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.人血浆中C3b/C4b受体(CR1)可溶性形式的特性研究
J Immunol. 1985 May;134(5):3332-8.
8
Characterization of CR1- and membrane cofactor protein-like proteins of two primates.两种灵长类动物CR1及膜辅因子蛋白样蛋白的特性分析
J Immunol. 1990 Jun 1;144(11):4262-8.
9
Rapid purification of the human C3b/C4b receptor (CR1) by monoclonal antibody affinity chromatography.
J Immunol Methods. 1985 Oct 10;82(2):303-13. doi: 10.1016/0022-1759(85)90362-x.
10
p65: A C3b-binding protein on murine cells that shares antigenic determinants with the human C3b receptor (CR1) and is distinct from murine C3b receptor.p65:一种存在于鼠细胞上的C3b结合蛋白,它与人C3b受体(CR1)具有共同的抗原决定簇,且与鼠C3b受体不同。
J Immunol. 1985 Jun;134(6):4048-56.

引用本文的文献

1
Evaluation of Tangential Flow Filtration for the Concentration and Separation of Bacteria and Viruses in Contrasting Marine Environments.切向流过滤用于对比海洋环境中细菌和病毒的浓缩与分离的评估
PLoS One. 2015 Aug 25;10(8):e0136741. doi: 10.1371/journal.pone.0136741. eCollection 2015.
2
STEVOR is a Plasmodium falciparum erythrocyte binding protein that mediates merozoite invasion and rosetting.疟原虫表面蛋白(STEVOR)是一种恶性疟原虫红细胞结合蛋白,可介导裂殖子入侵和红细胞凝聚。
Cell Host Microbe. 2014 Jul 9;16(1):81-93. doi: 10.1016/j.chom.2014.06.004.
3
Complement receptor 1 is a sialic acid-independent erythrocyte receptor of Plasmodium falciparum.

本文引用的文献

1
Limited chymotryptic cleavage of human C4-binding protein: isolation of a carbohydrate-containing core domain and an active fragment.人C4结合蛋白的有限胰凝乳蛋白酶裂解:含碳水化合物核心结构域和活性片段的分离
J Biochem. 1982 Oct;92(4):1329-32. doi: 10.1093/oxfordjournals.jbchem.a134052.
2
Purification of human C3b inactivator by monoclonal-antibody affinity chromatography.用单克隆抗体亲和层析法纯化人C3b灭活剂。
Biochem J. 1982 Apr 1;203(1):293-8. doi: 10.1042/bj2030293.
3
Human C4-binding protein: N-terminal amino acid sequence analysis and limited proteolysis by trypsin.
补体受体 1 是恶性疟原虫红细胞的非唾液酸依赖受体。
PLoS Pathog. 2010 Jun 17;6(6):e1000968. doi: 10.1371/journal.ppat.1000968.
4
Surface proteins and glycoproteins of human leucocytes.人类白细胞的表面蛋白和糖蛋白。
Biochem J. 1988 Jul 1;253(1):1-26. doi: 10.1042/bj2530001.
5
Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism.与补体受体1(CR1)等位基因分子量多态性相关的人类补体C3b/C4b受体(CR1)mRNA多态性。
Proc Natl Acad Sci U S A. 1987 Apr;84(8):2459-63. doi: 10.1073/pnas.84.8.2459.
6
Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.人C3b/C4b受体(CR1)。由C3/C4结合蛋白特征性的短共有重复序列组成的长同源重复结构域的证实。
J Exp Med. 1987 Apr 1;165(4):1095-112. doi: 10.1084/jem.165.4.1095.
7
Primary structure of human complement component C2. Homology to two unrelated protein families.人补体成分C2的一级结构。与两个不相关蛋白质家族的同源性。
Biochem J. 1986 Oct 15;239(2):339-45. doi: 10.1042/bj2390339.
8
Loss of complement receptor type 1 (CR1) on ageing of erythrocytes. Studies of proteolytic release of the receptor.红细胞衰老过程中补体受体1(CR1)的丧失。受体蛋白水解释放的研究。
Biochem J. 1986 May 1;235(3):815-21. doi: 10.1042/bj2350815.
FEBS Lett. 1982 Jan 11;137(1):75-9. doi: 10.1016/0014-5793(82)80318-9.
4
Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus.正常肾脏及75例肾脏疾病中人类肾小球C3b受体的免疫组织化学研究:局灶性玻璃样变和系统性红斑狼疮增殖性肾炎中C3b受体抗原缺失。
J Clin Invest. 1982 Apr;69(4):900-12. doi: 10.1172/jci110529.
5
Characteristics of isolated erythrocyte complement receptor type one (CR1, C4b-C3b receptor) and CR1-specific antibodies.分离的红细胞补体受体1型(CR1,C4b-C3b受体)及CR1特异性抗体的特性
J Immunol. 1981 Feb;126(2):693-8.
6
Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.系统性红斑狼疮患者红细胞中的补体受体(CR1)缺陷。
J Exp Med. 1982 May 1;155(5):1427-38. doi: 10.1084/jem.155.5.1427.
7
Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.鉴定作为人类红细胞、多形核白细胞、B淋巴细胞和单核细胞C3b受体的膜糖蛋白。
J Exp Med. 1980 Jul 1;152(1):20-30. doi: 10.1084/jem.152.1.20.
8
Complement receptor is an inhibitor of the complement cascade.补体受体是补体级联反应的一种抑制剂。
J Exp Med. 1981 May 1;153(5):1138-50. doi: 10.1084/jem.153.5.1138.
9
Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor.低离子强度或单体C3b的化学交联会增加其与人补体C3b受体的结合亲和力。
Immunology. 1983 Feb;48(2):229-37.
10
Polymorphism of human erythrocyte C3b/C4b receptor.人类红细胞C3b/C4b受体的多态性
Proc Natl Acad Sci U S A. 1983 Mar;80(6):1698-702. doi: 10.1073/pnas.80.6.1698.